Mostrar el registro sencillo del ítem

Clinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out

dc.contributor.authorNeumann, Hartmut P. H.
dc.contributor.authorErlic, Zoran
dc.contributor.authorBoedeker, Carsten Christof
dc.contributor.authorRybicki, Lisa A.
dc.contributor.authorRobledo, Mercedes
dc.contributor.authorSevilla García, María Agustina 
dc.contributor.authorHermsen, Mario 
dc.date.accessioned2016-03-14T16:52:37Z
dc.date.available2016-03-14T16:52:37Z
dc.date.issued2009
dc.identifier.citationCancer Research, 69(8), p. 3650-3656 (2009); doi:10.1158/0008-5472.CAN-08-4057
dc.identifier.issn0008-5472
dc.identifier.urihttp://hdl.handle.net/10651/35609
dc.description.sponsorshipGrant 107995 (H.P.H. Neumann), the Deutsche Forschungsgemeinschaft (NE 571/5-3; H.P.H. Neumann), and the European Union (LSHC-CT-2005-518200; H.P.H. Neumann). C. Eng is the recipient of a Doris Duke Distinguished Clinical Scientist Award, and is the Sondra J. and Stephen R. Hardis Endowed Chair of Cancer Genomic Medicine at the Cleveland Clinic. C. Suarez is supported by a grant from the Fondo de Investigaciones Sanitarias (FIS; PI052071) and Red Tematica de Investigacio ́n Cooperativa en Ca ́ncer (RD06/0020/0034). M. Robledo is supported by a grant from FIS (PI042154) and Centro de Investigacio ́n Biome ́dica En Red de Enfermedades Raras.
dc.description.statementofresponsibilityNeumann, H.P.H., Erlic, Z., Boedeker, C.C., Rybicki, L.A., Robledo, M., Hermsen, M., Schiavi, F., Falcioni, M., Kwok, P., Bauters, C., Lampe, K., Fischer, M., Edelman, E., Benn, D.E., Robinson, B.G., Wiegand, S., Rasp, G., Stuck, B.A., Hoffmann, M.M., Sullivan, M., Sevilla, M.A., Weiss, M.M., Peczkowska, M., Kubaszek, A., Pigny, P., Ward, R.L., Learoyd, D., Croxson, M., Zabolotny, D., Yaremchuk, S., Dra, W., Muresan, M., Lorenz, R.R., Knipping, S., Strohm, M., Dyckhoff, G., Matthias, C., Reisch, N., Preuss, S.F., Eßer, D., Walter, M.A., Kaftan, H., Stöver, T., Fottner, C., Gorgulla, H., Malekpour, M., Zarandy, M.M., Schipper, J., Brase, C., Glien, A., Kühnemund, M., Koseielny, S., Schwerdtfeger, P., Välimäki, M., Szyfter, W., Finckh, U., Zerres, K., Cascon, A., Opocher, G., Ridder, G.J., Januszewicz, A., Suarez, C., Eng, C.
dc.format.extentp. 3650-3656
dc.language.isoeng
dc.relation.ispartofCancer Research
dc.rights© 2009 American Association for Cancer Research
dc.sourceScopus
dc.source.urihttp://www.scopus.com/inward/record.url?eid=2-s2.0-66049145825&partnerID=40&md5=3f0bf7cf31134965931bb888a4cc60c4
dc.titleClinical predictors for germline mutations in Head and neck paraganglioma patients: cost reduction strategy in Genetic diagnostic process as fail-out
dc.typejournal article
dc.identifier.doi10.1158/0008-5472.CAN-08-4057
dc.relation.publisherversionhttp://dx.doi.org/10.1158/0008-5472.CAN-08-4057


Ficheros en el ítem

FicherosTamañoFormatoVer

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem